[1]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84-86.[doi:10.3969/j.issn.1006-1959.2022.09.021]
 CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(09):84-86.[doi:10.3969/j.issn.1006-1959.2022.09.021]
点击复制

HPV感染与宫颈病变相关性的研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年09期
页码:
84-86
栏目:
综述
出版日期:
2022-05-01

文章信息/Info

Title:
Study on the Correlation Between HPV Infection and Cervical Lesions
文章编号:
1006-1959(2022)09-0084-03
作者:
车 莹
(天津市滨海新区海滨人民医院感染管理部,天津 300280)
Author(s):
CHE Ying
(Department of Infection Management,Tianjin Binhai New Area Haibin People’s Hospital,Tianjin 300280,China)
关键词:
人乳头状瘤病毒宫颈癌宫颈上皮内瘤变病毒载量阴道菌群
Keywords:
Human papilloma virusCervical cancerCervical intraepithelial neoplasiaViral loadVaginal flora
分类号:
R543.4
DOI:
10.3969/j.issn.1006-1959.2022.09.021
文献标志码:
A
摘要:
人乳头瘤病毒(HPV)是女性生殖道及皮肤黏膜常见致病菌,其感染率非常普遍,可引起鳞状上皮细胞增殖,在宫颈病变的发生发展中具有重要作用。现阶段,临床关于HPV感染与宫颈病变相关性的研究多集中在HPV分型、病毒载量及阴道菌群等方面。现本文结合HPV的生物学基础,对HPV感染与宫颈病变的相关性研究进展作一综述,以供参考。
Abstract:
Human papillomavirus (HPV) is a common pathogen of female genital tract and skin mucosa. Its infection rate is very common, which can cause the proliferation of squamous epithelial cells and plays an important role in the occurrence and development of cervical lesions. At present, the clinical research on the correlation between HPV infection and cervical lesions mainly focuses on HPV typing, viral load and vaginal flora. Based on the biological basis of HPV, this paper reviews the research progress on the correlation between HPV infection and cervical lesions for reference.

参考文献/References:

[1]Kitagawa R,Nakanishi T,Fukaya T,et al.[Ⅱ.Current Topics and Perspective of Chemotherapy for Uterine Cervical Cancer][J].Gan To Kagaku Ryoho,2017,44(2):126-130.[2]刘小花,龙红惠,陈宇宁,等.高危HPV感染与宫颈病变的相关性分析[J].中国优生与遗传杂志,2020,28(8):1008-1009,1028.[3]Qian L,Zhang Y,Cui D,et al.Analysis of epidemiological trends in human papillomavirus infection among gynaecological outpatients in Hangzhou,China,2011-2015[J].BMC Infect Dis,2017,17(1):393.[4]陈丽媛,朱晓云.阴道上皮内瘤变与高危型HPV感染、TCT、宫颈病变的相关性分析[J].临床检验杂志(电子版),2019,8(1):79-80.[5]Wu Z,Qin Y,Yu L,et al.Association between humanpapillomavirus(HPV)16,HPV18,and other HR-HPV viralload and the histological classification of cervical lesions:results from a large-scale cross-sectional study[J].Journal of Medical Virology,2017,89(3):535-541.[6]苗野,阮强,马艳萍.不同人乳头瘤病毒亚型感染与宫颈病变的相关性[J].中国医科大学学报,2019,48(7):606-610,614.[7]方莉,韩瑜,许媛,等.高危型HPV感染与宫颈癌前病变及宫颈癌的相关性研究[J].中国实验诊断学,2019,23(4):602-605.[8]李丽,杨亚玲,闫翠起,等.陕西地区宫颈病变患者HR-HPV感染的流行病学调查及与宫颈病变的相关性分析[J].解放军预防医学杂志,2018,36(9):1197-1199.[9]杨小飞,谢宁娜,宋淑芳.内蒙中部地区妇科门诊就诊患者宫颈HPV感染及与宫颈病变相关性的研究[J].现代妇产科进展,2018,27(6):446-451.[10]金龙妹,徐灵,肖丽萍,等.人乳头瘤病毒多重感染与宫颈病变的相关性分析[J].上海预防医学,2018,30(6):523-528.[11]郑家凤,周燕.HPV多重感染与宫颈癌及癌前病变发生、发展的相关性[J].实用癌症杂志,2019,34(7):1107-1109,1131.[12]赵钦.女性宫颈高危型HPV感染与宫颈病变的相关性[J].黑龙江医药,2017,30(5):1117-1119.[13]张毅,王建军.不同高危型HPV感染与宫颈癌及宫颈高级别病变的相关性[J].同济大学学报(医学版),2018,39(3):59-63.[14]钟兴明,杜明娣,荆春霞,等.高危型HPV持续感染与宫颈癌前病变的相关性[J].中国热带医学,2018,18(3):267-270.[15]王国荣,韩延霞.高危型人乳头瘤病毒16、18型感染与宫颈癌及癌前病变的相关性分析[J].中国妇幼保健,2018,33(1):67-69.[16]朱静,牛红梅,郑锦丽,等.宫颈高危型人乳头瘤病毒感染与宫颈病变相关性研究[J].中国性科学,2017,26(2):32-34.[17]Ma L,Cong X,Shi M,et al.Distribution of humanpapillomavirus genotypes in cervical lesions[J].Experimental and Therapeutic Medicine,2017,13(2):535-541.[18]Sun Z,Zhang R,Liu Z,et al.Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads[J].BMC Cancer,2015,15(6):860-870.[19]罗攀.宫颈癌筛查人群中HPV感染情况与宫颈病变的相关性分析[J].医学理论与实践,2021,34(4):556-558,549.[20]裴蕴锋,经先振,周娟,等.医院就诊人群HPV感染的流行病学特征及其与宫颈癌/癌前病变的关系[J].华中科技大学学报,2018,47(3):349-353.[21]蒋盈盈,徐玮,陶俊贞.高危人乳头瘤病毒感染状况及其与宫颈病变的相关性分析[J].中国妇幼健康研究,2020,31(5):671-675.[22]董宇凤,高丽.HPV感染与宫颈病变的相关性及常见危险因素[J].中国性科学,2016,25(5):35-37.[23]Wang W,Zhang XH,Li M,et al.Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer[J].Clinica Chimica Acta,2018(483):249-255.[24]李艳芳,王海如,侯亚彬,等.人乳头瘤病毒载量与宫颈病变程度的相关性[J].中国医师杂志,2021,23(3):419-422.[25]李焕勇,应玲娣,孙爱华.高危型人乳头瘤病毒感染与宫颈病变及阴道微生态异常的关系[J].中国艾滋病性病,2021,27(7):767-769.[26]Holt HK,Zhang L,Zhao FH,et al.Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China[J].International Journal of Cancer,2017,140(3):544-554.[27]韦彩素,陈慧峰,李建湘,等.子宫颈病变患者阴道微生态环境与HR-HPV感染的相关性及子宫颈病变的影响因素分析[J].中外医学研究,2021,19(17):4-7.[28]潘颖,盛华芳,康玲,等.高危型人乳头状瘤病毒感染与阴道菌群的相关性研究[J].第三军医大学学报,2016,38(13):1559-1564.[29]张朋云,王东红,张振东,等.阴道微生态和高危型HPV感染与宫颈病变的相关性[J].中华医院感染学杂志,2018,28(21):3305-3307,3311.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
 LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(09):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
 XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
 CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[4]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
 CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[5]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
 QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(09):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[6]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
 HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(09):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[7]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
 XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(09):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[8]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
 YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(09):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[9]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
 WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Medical Information,2018,31(09):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[10]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
 NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Medical Information,2018,31(09):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[11]王燕华,杨 如,李 伟,等.2016~2018年苏州市育龄妇女HPV感染因素分析[J].医学信息,2019,32(22):117.[doi:10.3969/j.issn.1006-1959.2019.22.038]
 WANG Yan-hua,YANG Ru,LI Wei,et al.Analysis of HPV Infection Factors in Women of Childbearing Age in Suzhou from 2016 to 2018[J].Medical Information,2019,32(09):117.[doi:10.3969/j.issn.1006-1959.2019.22.038]

更新日期/Last Update: 1900-01-01